| Document Date: 2014-11-03 11:26:18
Open Document File Size: 14,60 KBShare Result on Facebook
City Osaka / Kobe / / Company Eli Lilly Japan / Eli Lilly and Company / Shionogi & Co. Ltd. / Corporate Communications Department Shionogi & Co. Ltd. / / Country Japan / United States / / Currency JPY / / Event FDA Phase / Product Release / / / IndustryTerm depressive symptoms treatment / manufacturing approval / treatment for depression / foreign healthcare reforms / with respect to product / / Person Isao Teshirogi / Alfonso G. Zulueta / / / Position President / President and General Manager / / Product Cymbalta / Eli Lilly Japan K.K. / Cymbalta® Capsules / /
SocialTag |
April 16, 2010 Shionogi & Co., Ltd. Eli Lilly Japan K.K. Launch of an Antidepressant Drug, “Cymbalta® Capsules 20mg and 30mg” Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President: Isao Teshirogi; hereafter “